Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pozanicline reverses nicotine withdrawal-induced cognitive deficits, may be an effective component of novel therapeutic strategies for nicotine addiction. Pozanicline selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a novel cholinergic agent that is a partial agonist at α4β2 nAChRs (Ki=16 nM). It shows high selectivity for α6β2 and α4α5β2 nAChR subtypes, the binding affinity (Ki, rat) for Pozanicline to [3H] cytisine sites is 16.7 nM .
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | 1-2 weeks | |
50 mg | 1.881 € | 1-2 weeks | |
100 mg | 2.375 € | 1-2 weeks |
Description | Pozanicline reverses nicotine withdrawal-induced cognitive deficits, may be an effective component of novel therapeutic strategies for nicotine addiction. Pozanicline selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a no |
Targets&IC50 | nAChR:(ki)16 nM |
Alias | ABT-089 |
Molecular Weight | 192.26 |
Formula | C11H16N2O |
Cas No. | 161417-03-4 |
Relative Density. | 1.046g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.